Literature DB >> 25693664

Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study.

Jean-François Deux1, Cristian-Ionut Mihalache, François Legou, Thibaud Damy, Julie Mayer, Stéphane Rappeneau, Violaine Planté-Bordeneuve, Alain Luciani, Hicham Kobeiter, Alain Rahmouni.   

Abstract

OBJECTIVES: To evaluate myocardial enhancement of patients with cardiac amyloidosis (CA) using computed tomography (CT).
METHODS: Thirteen patients with CA and 11 control patients were examined with first-pass and delayed CT acquisition. A qualitative and quantitative analysis of images was performed. Myocardial attenuation, myocardial signal-to-noise ratio (SNRmyoc), blood pool SNR (SNRblood), contrast-to-noise ratio between blood pool and myocardium (CNRblood-myoc) and relative attenuation index (RAI) defined as variation of myocardial attenuation between delayed and first-pass acquisitions were calculated.
RESULTS: Two false negative cases (15 %) and three false positive cases (27 %) were detected on qualitative analysis. SNRmyoc of patients with CA was significantly (p < 0.05) lower on first-pass (4.08 ± 1.9) and higher on delayed acquisition (7.10 ± 2.7) than control patients (6.1 ± 2.2 and 5.03 ± 1.8, respectively). Myocardial attenuation was higher in CA (121 ± 39 HU) than control patients (81 ± 17 HU) on delayed acquisition. CNRblood-myoc was significantly (p < 0.05) lower in CA (1.51 ± 0.7) than control patients (2.85 ± 1.2) on delayed acquisition. The RAI was significantly (p < 0.05) higher in CA (0.12 ± 0.25) than in control patients (-0.56 ± 0.21).
CONCLUSION: Dual phase MDCT can detect abnormal myocardial enhancement in patients with CA. KEY POINTS: • CT can detect abnormal first-pass and delayed enhancement in cardiac amyloidosis. • Measurement of relative myocardial enhancement between acquisitions helps to detect cardiac amyloidosis. • CT may provide useful data to diagnose cardiac amyloidosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693664     DOI: 10.1007/s00330-015-3642-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

Review 1.  Magnetic resonance perfusion imaging in ischemic heart disease.

Authors:  E P Canet; M F Janier; D Revel
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

Review 2.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

3.  Prognostic value of myocardial contrast delayed enhancement with 64-slice multidetector computed tomography after acute myocardial infarction.

Authors:  Akira Sato; Toshihiro Nozato; Hiroyuki Hikita; Daiki Akiyama; Hidetaka Nishina; Tomoya Hoshi; Hideaki Aihara; Yuki Kakefuda; Hiroaki Watabe; Michiaki Hiroe; Kazutaka Aonuma
Journal:  J Am Coll Cardiol       Date:  2012-02-21       Impact factor: 24.094

4.  Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT.

Authors:  Timo Baks; Filippo Cademartiri; Amber D Moelker; Willem J van der Giessen; Gabriel P Krestin; Dirk J Duncker; Pim J de Feyter
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

5.  Diagnostic value of ECG-gated multidetector computed tomography in the early phase of suspected acute myocarditis. A preliminary comparative study with cardiac MRI.

Authors:  Grégoire Dambrin; Jean Pierre Laissy; Jean Michel Serfaty; Christophe Caussin; Bernard Lancelin; Jean François Paul
Journal:  Eur Radiol       Date:  2006-09-05       Impact factor: 5.315

6.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

7.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

8.  Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention.

Authors:  Gastón A Rodriguez-Granillo; Miguel A Rosales; Santiago Baum; Paola Rennes; Carlos Rodriguez-Pagani; Valeria Curotto; Carlos Fernandez-Pereira; Claudio Llaurado; Gustavo Risau; Elina Degrossi; Hernán C Doval; Alfredo E Rodriguez
Journal:  JACC Cardiovasc Imaging       Date:  2009-09

9.  Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging.

Authors:  Koen Nieman; Michael D Shapiro; Maros Ferencik; Cesar H Nomura; Suhny Abbara; Udo Hoffmann; Herman K Gold; Ik-Kyung Jang; Thomas J Brady; Ricardo C Cury
Journal:  Radiology       Date:  2008-04       Impact factor: 11.105

10.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364

View more
  10 in total

Review 1.  Computed tomography of cardiomyopathies.

Authors:  Kevin Kalisz; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2017-10

Review 2.  Delayed enhancement cardiac computed tomography for the assessment of myocardial infarction: from bench to bedside.

Authors:  Gaston A Rodriguez-Granillo
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

3.  Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study.

Authors:  Tadao Aikawa; Noriko Oyama-Manabe; Masanao Naya; Hiroshi Ohira; Ayako Sugimoto; Ichizo Tsujino; Masahiko Obara; Osamu Manabe; Kohsuke Kudo; Hiroyuki Tsutsui; Nagara Tamaki
Journal:  Eur Radiol       Date:  2017-04-05       Impact factor: 5.315

Review 4.  The Role of Cardiac Computed Tomography in Heart Failure.

Authors:  Spencer S Kitchin; Venkat Sanjay Manubolu; Sion K Roy; Matthew J Budoff
Journal:  Curr Heart Fail Rep       Date:  2022-05-19

5.  Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study.

Authors:  Virgile Chevance; Thibaud Damy; Vania Tacher; François Legou; Fourat Ridouani; Alain Luciani; Hicham Kobeiter; Alain Rahmouni; Jean-François Deux
Journal:  Eur Radiol       Date:  2017-08-10       Impact factor: 5.315

Review 6.  SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography.

Authors:  Jagat Narula; Y Chandrashekhar; Amir Ahmadi; Suhny Abbara; Daniel S Berman; Ron Blankstein; Jonathon Leipsic; David Newby; Edward D Nicol; Koen Nieman; Leslee Shaw; Todd C Villines; Michelle Williams; Harvey S Hecht
Journal:  J Cardiovasc Comput Tomogr       Date:  2020-11-20

Review 7.  Assessment of Left Ventricular Myocardial Diseases with Cardiac Computed Tomography.

Authors:  Sung Min Ko; Tae Hoon Kim; Eun Ju Chun; Jin Young Kim; Sung Ho Hwang
Journal:  Korean J Radiol       Date:  2019-03       Impact factor: 3.500

Review 8.  Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis.

Authors:  Jyothirmayi Velaga; Charlene Liew; Angeline Choo Choo Poh; Phong Teck Lee; Narayan Lath; Shoen Choon Low; Pushan Bharadwaj
Journal:  World J Nucl Med       Date:  2022-08-16

Review 9.  Cardiac Amyloidosis: Multimodal Imaging of Disease Activity and Response to Treatment.

Authors:  Rishi K Patel; Marianna Fontana; Frederick L Ruberg
Journal:  Circ Cardiovasc Imaging       Date:  2021-06-15       Impact factor: 8.589

Review 10.  The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.

Authors:  Shaun Khanna; Ivy Wen; Aditya Bhat; Henry H L Chen; Gary C H Gan; Faraz Pathan; Timothy C Tan
Journal:  Front Cardiovasc Med       Date:  2020-10-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.